Laurion Capital Management LP Pliant Therapeutics, Inc. Transaction History
Laurion Capital Management LP
- $11.4 Billion
- Q1 2024
A detailed history of Laurion Capital Management LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 3,474,744 shares of PLRX stock, worth $36.8 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
3,474,744
Previous 3,583,567
3.04%
Holding current value
$36.8 Million
Previous $64.9 Million
20.22%
% of portfolio
0.45%
Previous 0.57%
Shares
4 transactions
Others Institutions Holding PLRX
# of Institutions
148Shares Held
63.8MCall Options Held
417KPut Options Held
123K-
Deep Track Capital, LP Greenwich, CT5.75MShares$61 Million2.83% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$49.3 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$42 Million0.01% of portfolio
-
First Light Asset Management, LLC Edina, MN3.53MShares$37.5 Million4.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$36.9 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $516M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...